Navigation Links
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
Date:3/26/2012

stonishing finding," Dr. Buller said. "Rivaroxaban is just as good as standard treatment for PE these data are pretty convincing and this is an oral-only approach, which makes it very simple. The subcutaneous injections can be hazardous as well."

Researchers also will be doing a subgroup analysis of the 8,200 patients in the EINSTEIN-PE and EINSTEIN-DVT trials to see if they can identify a risk profile for patients who are likely to have bleeding problems on standard treatment or the new drug.


'/>"/>
Contact: Beth Casteel
bcasteel@acc.org
240-328-4549
American College of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel mouse model for autism yields clues to a 50-year-old mystery
2. Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism
3. Novel plastics and textiles from waste with the use of microbes
4. UC San Diego among first in nation to treat brain cancer with novel viral vector
5. Students at Western University develop a novel way to teach interdisciplinary care
6. UH Case Medical Center publishes study on novel treatment for skin lymphoma
7. Mass. General researchers find novel way to prevent drug-induced liver injury
8. Rutgers, Massachusetts General investigators find novel way to prevent drug-induced liver injury
9. NIH scientists identify novel approach to view inner workings of viruses
10. Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes
11. KalVista and JDRF form research partnership for novel treatment of diabetic eye disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... SC (PRWEB) May 26, 2015 On May ... by Oceans 6 salesman and distributor Dwayne Windfall. At the ... food supply company that has some unique characteristics with it, ... the food business?” Windfall replies saying, “I was reading the ... ad that said they were looking for a person with ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... USA (PRWEB) May 26, 2015 Based ... site, AnyTranscription has undertaken a comprehensive upgrade of its ... in user experience. To thank users for their feedback ... this five minute trial transcription service promotion. ... from May 26 to June 9 this year. During ...
(Date:5/26/2015)... 2015 Adenna, Inc ., worldwide ... excited to announce the launch of Enov8 ... made of polyethylene (PE) and approved by the U.S. ... , The Enov8 glove might look like ... mixing salads but our proprietary formula and production technology ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2
... 6 Medical professionals,have long sought new treatments for ... A new therapy, based on,hypnosis, is currently being tested ... of surgery., Your Cancer Today interviews Guy H. ... Montgomery,s study looked at two groups of patients,facing surgery ...
... women surveyed about their beliefs surrounding miscarriage and birth defects ... negatively affect her baby. , One in four of ... could hurt her unborn child, and one in five believed ... Despite those beliefs, relatively few of the women surveyed blamed ...
... WHITE PLAINS, N.Y., DECEMBER 5, 2007 The preterm birth ... show a continued increase, underscoring the urgent need for a ... The more we learn about the terrible consequences of an ... to understand what causes preterm birth and how it can ...
... 6, 2007 -- A new study recently published in the ... novel benefit in slenderizing thighs. , The Brazilian researchers studied ... 7 percent caffeine solution. The women used the cream twice ... their subjects measurements at the end of the study, the ...
... Taking ,Unacceptable Risk, With Patient, FORT WORTH, Texas, ... million to the family of a 75-year-old Fort Worth ... his symptoms., Jurors deliberated about six hours over ... 236th District Court of Judge Thomas W. Lowe III.,The ...
... $24 Million Worth of,Prescription Drugs Through Rogue Internet ... Lifestyle, Including Seven,Convertibles, Four Stretch Limousines & Maybach ... National Health,Care Anti-Fraud Association (NHCAA) today is presenting ... and Treasury the 2007,Fraud "Investigation of the Year" ...
Cached Medicine News:Health News:Reducing Pain via Hypnosis, This Week on Your Cancer Today (TM) 2Health News:Miscarriage myths persist despite prevalence of medical information 2Health News:Miscarriage myths persist despite prevalence of medical information 3Health News:Miscarriage myths persist despite prevalence of medical information 4Health News:Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 3
(Date:5/26/2015)... NEW YORK , May 26, 2015  Shapiro+Raj, ... Kim Mizrahi , PhD, to Managing Director. In ... York strategy for CarbonSix, Shapiro+Raj,s pharmaceutical practice ... capability. Shapiro+Raj has been on a strong ... adding a number of new assignments from existing clients ...
(Date:5/26/2015)... 2015  Caris Life Sciences®, a leading biotechnology company ... announced the designation of Virginia Cancer Specialists ... serving thousands of cancer patients each year ... center of excellence site in the Caris Centers of ... "As the largest community-based practice in the northern ...
(Date:5/26/2015)... 26, 2015 For the Last ... of Life Throughout Europe, the Middle East ... Astellas Pharma EMEA is celebrating its 10 year ... the historic merger of Japanese pharmaceutical companies Yamanouchi and ... to turning science into value for patients through its ...
Breaking Medicine Technology:Shapiro+Raj Promotes Kim Mizrahi to Managing Director for New York 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 3Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 4Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4
... Sangart, Inc., a privately,held biopharmaceutical company focused ... today announced that it has,completed enrollment in a ... The completed study of 460 patients is ... conducted at 36 academic medical centers in the,United ...
... After completing its review of safety,and efficacy ... (DSMB) has once again recommended that the two ... FAME(TM) (Fluocinolone,Acetonide in Diabetic Macular Edema) Study can ... is studying the use of Medidur FA for,the ...
Cached Medicine Technology:Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 3
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: